Author:
Romanelli Robert J.,Huang Qiwen,Lacy Joseph,Hashemi Lobat,Wong Alana,Smith Alden
Abstract
Abstract
Background
Research is needed to examine differences in multiple sclerosis (MS) prevalence by race-ethnicity. The goal of this study was to quantify MS prevalence in a health care system in Northern California and examine differences in prevalence and phenotype by race-ethnicity.
Methods
We conducted a retrospective, observational cohort study of adults (2010–2016). MS prevalence estimates were standardised to distributions of gender and race-ethnicity for the underlying geographic region and stratified by gender and race-ethnicity with age adjustment. We performed a chart review of a racial-ethnic stratified sample of patients to examine disease phenotypes.
Results
1,058,102 patients were identified, of which 3286 had MS. The overall direct-standardised prevalence was 288.0 cases per 100,000 population (95% confidence interval: 276.3–299.8). Age-adjusted prevalence ranged from 677.0 per 100,000 among non-Hispanic black women to 49.7 per 100,000 among non-Hispanic Asian men. Non-Hispanic blacks compared with other groups more often had primary-progressive (10.0% vs. 0.0–4.0%) or progressive-relapsing MS (6.0% vs. 0.0–2.0%).
Conclusions
In this Northern Californian Cohort, between 2010 and 2016 the direct-standardised MS prevalence was estimated at 288.0 per 100,000 population, and increased over time. Non-Hispanic blacks, especially women, were disproportionately affected and had less common, earlier progressive MS phenotypes.
Publisher
Springer Science and Business Media LLC
Subject
Clinical Neurology,General Medicine
Reference18 articles.
1. Healthline. Multiple sclerosis: facts, statistics, and you. http://www.healthline.com/health/multiple-sclerosis/facts-statistics-infographic. Accessed 14 Mar 2019.
2. Wallin MT, Culpepper WJ, Campbell JD, Nelson LM, Langer-Gould A, Marrie RA, et al. The prevalence of multiple sclerosis in the United States: a population-based estimate using health claims data. Neurology. 2019;92(1):e1029–40.
3. Alter M. Etiological considerations based on the epidemiology of multiple sclerosis. Am J Epidemiol. 1968;88:318–32.
4. Alter M, Loewenson R, Harshe M. The geographic distribution of multiple sclerosis: an examination of mathematical models. J Chron Dis. 1973;26:755–67.
5. Weinshenker BG. Epidemiology of multiple sclerosis. Neurol Clin. 1996;14:291–308.
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献